Strokes, statistics and sophistry in trials of thrombolysis for acute myocardial infarction.
Sobel
B E
BE
Collen
D
D
D002543:Cerebral Hemorrhage / Q000453:epidemiology*; D002561:Cerebrovascular Disorders / Q000453:epidemiology*; D003627:Data Interpretation, Statistical; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000453:epidemiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D012107:Research Design; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D006493:Heparin; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; C068645:duteplase